Literature DB >> 9576581

T-cell subset analysis of peripheral T-cell lymphomas by paraffin section immunohistology and correlation of CD4/CD8 results with flow cytometry.

W R Macon1, K E Salhany.   

Abstract

Peripheral T-cell lymphomas (PTCLs) are often diagnosed after demonstration of T-lineage-related antigen expression on neoplastic lymphocytes by paraffin immunoperoxidase (PIP). However, complete T-cell subset analysis for helper, suppressor/cytotoxic, alphabeta, and gammadelta phenotypes has not been examined by PIP. Therefore, PIP was performed for CD4, CD8, T-cell intracellular antigen (TIA)-1, and betaF1 expression in 31 PTCLs previously studied for CD4 and CD8 by flow cytometry. The CD4 and CD8 results from both methods were compared. All betaF1- PTCLs were studied for T-cell receptor (TCR)gammadelta by PIP. PIP showed 71% correlation with the 21 PTCLs that had distinct CD4+ CD8- or CD4- CD8+ phenotypes by flow cytometry, with 64% and 90% sensitivity for CD4 and CD8 expression, respectively. Tumor cells in four of six PTCLs that had no clear CD4 or CD8 predominance or coexpression of these antigens by flow cytometry were shown to be CD4+ CD8- or CD4- CD8+ by PIP. Twelve (39%) PTCLs demonstrated a cytotoxic (TIA-1+) phenotype by PIP, including eight CD4- CD8+, one CD4+ CD8- and three CD4- CD8- cases. Of 30 immunoreactive PTCLs, 26 (87%) were alphabeta (betaF1+) by PIP. Both large cell cases among four betaF1- PTCLs were TCRgammadelta+ by PIP, including one gammadelta+ case confirmed by flow cytometry. We conclude that CD4 and CD8 T-cell subsets can be assigned for most PTCLs by PIP, with CD4 showing moderate and CD8 showing strong correlation with flow cytometric results. PIP can also define CD4 or CD8 expression on tumor cells in the PTCLs in which flow cytometry produces inconclusive results. Cytotoxic PTCLs can be identified easily with TIA-1, which can also distinguish cytotoxic from "suppressor" CD8+ PTCLs. Most PTCLs are derived from alphabeta T-cells, however some large cell gammadelta PTCLs may be identified by PIP.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9576581     DOI: 10.1093/ajcp/109.5.610

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  9 in total

1.  Utility of flow cytometry in subtyping composite and sequential lymphoma.

Authors:  J D Siebert; D A Mulvaney; A M Vukov; J A Knost; D E King; F E Craig
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

2.  HIV target cells in Schistosoma haematobium-infected female genital mucosa.

Authors:  Peter Mark Jourdan; Sigve Dhondup Holmen; Svein Gunnar Gundersen; Borghild Roald; Eyrun Floerecke Kjetland
Journal:  Am J Trop Med Hyg       Date:  2011-12       Impact factor: 2.345

3.  Nodal peripheral T-cell lymphomas and, in particular, their lymphoepithelioid (Lennert's) variant are often derived from CD8(+) cytotoxic T-cells.

Authors:  Eva Geissinger; Tobias Odenwald; Seung-Sook Lee; Irina Bonzheim; Sabine Roth; Peter Reimer; Martin Wilhelm; Hans Konrad Müller-Hermelink; Thomas Rüdiger
Journal:  Virchows Arch       Date:  2004-07-29       Impact factor: 4.064

4.  Trophic factor induction of human umbilical cord blood cells in vitro and in vivo.

Authors:  Ning Chen; Siddharth Kamath; Jennifer Newcomb; Jennifer Hudson; Svitlana Garbuzova-Davis; Paula Bickford; Cyndy Davis-Sanberg; Paul Sanberg; Tanja Zigova; Alison Willing
Journal:  J Neural Eng       Date:  2007-04-04       Impact factor: 5.379

5.  Hepatosplenic gammadelta T-cell lymphoma.

Authors:  Shuan-Zeng Wei; Tong-Hua Liu; De-Tian Wang; Jin-Ling Cao; Yu-Feng Luo; Zhi-Yong Liang
Journal:  World J Gastroenterol       Date:  2005-06-28       Impact factor: 5.742

6.  Nonhepatosplenic γδ T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentation.

Authors:  Adriana Garcia-Herrera; Joo Y Song; Shih-Sung Chuang; Neus Villamor; Luis Colomo; Stefania Pittaluga; Tomas Alvaro; Maria Rozman; Jazmin de Anda Gonzalez; Ana Maria Arrunategui; Eva Fernandez; Elena Gonzalvo; Teresa Estrach; Dolors Colomer; Mark Raffeld; Philippe Gaulard; Elias Campo; Elaine S Jaffe; Antonio Martinez
Journal:  Am J Surg Pathol       Date:  2011-08       Impact factor: 6.394

7.  Identification of the tumor cells in peripheral T-cell lymphomas by combined polymerase chain reaction-based T-cell receptor beta spectrotyping and immunohistological detection with T-cell receptor beta chain variable region segment-specific antibodies.

Authors:  Eva Geissinger; Irina Bonzheim; László Krenács; Sabine Roth; Philipp Ströbel; German Ott; Peter Reimer; Martin Wilhelm; Hans Konrad Müller-Hermelink; Thomas Rüdiger
Journal:  J Mol Diagn       Date:  2005-10       Impact factor: 5.568

8.  T-cell-rich large-B-cell lymphomas contain non-activated CD8+ cytolytic T cells, show increased tumor cell apoptosis, and have lower Bcl-2 expression than diffuse large-B-cell lymphomas.

Authors:  R E Felgar; K R Steward; J B Cousar; W R Macon
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

9.  Clinical features, treatment and risk factors for interstitial pneumonia in B-cell non-Hodgkin lymphoma patients.

Authors:  Cong Li; Fangxiao Lu; Tao Lei; Haifeng Yu; Haiyan Yang
Journal:  Transl Cancer Res       Date:  2020-09       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.